Amphastar Pharmaceuticals (AMPH) Treasury Shares (2014 - 2026)

Amphastar Pharmaceuticals' Treasury Shares history runs 13 years deep, the most recent figure standing at $438.0 million for Q1 2026.

• In Q1 2026, Treasury Shares rose 27.35% year-over-year to $438.0 million; the TTM figure through Mar 2026 stood at $438.0 million (up 27.35% YoY), while the FY2025 annual figure was $408.1 million, up 22.67% from the prior year.
• Treasury Shares was $438.0 million for Q1 2026 at Amphastar Pharmaceuticals, up from $408.1 million in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $1.5 million in Q2 2025 to a low of -$16.1 million in Q4 2025.
• Historically, Treasury Shares has averaged -$4.0 million across 5 years, with a median of $172920.0 in 2025.
• The sharpest annual moves came in 2024 and 2025: Treasury Shares climbed 17.51% in 2024, then jumped 49.67% in 2025.
• A 5-year view of Treasury Shares shows it stood at $189.5 million in 2022, then jumped by 30.55% to $247.4 million in 2023, then jumped by 34.47% to $332.7 million in 2024, then increased by 22.67% to $408.1 million in 2025, then grew by 7.31% to $438.0 million in 2026.
• The last three Treasury Shares figures came in at $438.0 million (Q1 2026), $408.1 million (Q4 2025), and $387.7 million (Q3 2025), per Business Quant data.